The largest database of trusted experimental protocols

5 protocols using cd133 apc

1

Flow Cytometry Analysis of Stem Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
50 000 viable B16-F10 cells (trypan blue exclusion test) dissociated from one-week-old tumorspheres or from trypsinized adherent monolayers were incubated for 30 minutes at 4°C in the dark with 0.5 µg of rat anti-mouse monoclonal CD133-APC, CD44-FITC or CD24-PE antibodies (eBiosciences, Paris, France) in 100 µL of a buffer solution consisting in PBS containing 3% bovine serum albumin (Sigma). Immunostaining was also performed for HT-29, MCF-7 and MDA-MB-231 cell lines using mouse anti-human monoclonal CD133-APC, CD44-PE, CD44-APC or CD24-FITC antibodies (Miltenyi Biotec, Paris, France) according to the manufacturer’s instructions. Cells were then washed and analyzed with an Accuri C6 flow cytometer (BD biosciences, USA).
+ Open protocol
+ Expand
2

Multiparametric Cytometry of Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibodies CD31-FITC, CD45-PerCP, and CD146-PE were purchased from BioLegend (San Diego, CA, USA) and CD133-APC from eBiosciences (San Diego, CA, USA). Hoechst 33342 stain was obtained from Sigma (St. Louis, MO, USA). The ELISA kits used were ST2 (DST200; R&D Systems Quantikine®, Minneapolis, MN, USA), VCAM1, ICAM1, and TIM3 (DY809, DY720, and DY2365; R&D Systems Duosets®, Minneapolis, MN, USA) and REG3α (Cat. No. 5323; Ab-Match Assembly Human PAP1 [REG3α] kit, MBL International Corp, Japan).
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed as described by Buono et al. (2015) (link) using the following antibodies specified in Tables S3 and S4). Lewis-X (1/20; BD Biosciences), CD133-APC (1/50; eBioscience), CD140a (1/400; BioLegend), and NG2 chondroitin sulfate proteoglycan (1/50; Millipore). EdU experiments were performed as described previously (Chen et al., 2015 ). Goat anti-rabbit IgG Alexa Fluor 700 (1/100; Invitrogen) was used for NG2. DAPI was used for dead cell exclusion. IL-6Rα was analyzed using the flow panel described above with the addition of an antibody against IL-6Rα (1/20, R&D Systems). All sample data were collected on a BD LSR II (BD Biosciences) and analyzed using FlowJo.
+ Open protocol
+ Expand
4

Characterization of Endothelial Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibodies CD31‐FITC, CD45‐PerCP, and CD146‐PE were purchased from BioLegend (San Diego, CA, USA) and CD133‐APC from eBiosciences (San Diego, CA, USA). Hoechst 33342 stain was obtained from Sigma (St. Louis, MO, USA). The ELISA kits used were ST2 (DST200; R&D Systems Quantikine®, Minneapolis, MN, USA), VCAM1, ICAM1, and TIM3 (DY809, DY720, and DY2365; R&D Systems Duosets®, Minneapolis, MN, USA) and REG3α (Cat. No. 5323; Ab‐Match Assembly Human PAP1 [REG3α] kit, MBL International Corp, Japan).
+ Open protocol
+ Expand
5

Characterization of Stem Cell Subpopulations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spheres were dissociated and counted as previously described (Buono et al., 2012) (see supplemental methods). For surface marker analysis, cells were incubated in PGB for 25 min with antibodies against Lewis-X (1:20, LeX/CD15 FITC, MMA; BD Bioscience), CD133-APC (1:50,13A4; eBioscience), CD140a (1:400, APA5; BioLegend) and NG2 Chondroitin Sulfate Proteoglycan (1:50, AB5320; Millipore). Goat anti-rabbit IgGAlexa Fluor 700 (1:100; Invitrogen) was used for NG2. All sample data were collected on the BD LSR II (BD Biosciences Immunocytometry Systems). Post-acquisition analysis was performed using FlowJoX (Tree Star Inc, Ashland, OR).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!